Journal of ethnopharmacology · 2026
Traditional Chinese medicine in coronary heart disease: A review of advances and therapeutic strategies.
СтатьяОбзорНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Shi Jiaxin, Guan Rui, Jia Zhaoyu, Han Yuli, Liu Changqing, Miao Xiaoyu, Zhang Ting, Zhang Huan, Du Kunze, Li Jin, Jin Hua, Chen Shujing, Chang Yanxu
Аннотация
ETHNOPHARMACOLOGICAL RELEVANCE: Coronary atherosclerotic heart disease (CHD) is a chronic and progressive condition influenced by multiple factors. Traditional Chinese medicines (TCMs) are widely used for treating CHD. However, the relevant mechanisms-are still not fully understood. Consequently, an in-depth investigation and synthesis of the therapeutic mechanism underlying TCMs interventions for CHD is of critical importance.
AIM OF THE REVIEW: This article provides a summary of the research developments on potential pharmacological mechanisms of TCMs formulas, TCMs extracts and chemical composition in the treatment of CHD. It aims to offer the detailed information and references for exploring new methods of treating CHD based on TCMs therapeutic strategies.
MATERIALS AND METHODS: A comprehensive literature search was conducted in databases including CNKI, Web of Science, Elsevier, and PubMed to identify studies published between 2019 and 2025 on the experimental effects of TCMs in treating CHD. The search strategy employed keywords including "coronary heart disease and traditional Chinese medicine", "coronary heart disease and inflammation", "coronary heart disease and oxidative stress", "coronary heart disease and miRNA". Retrieved articles were screened and analyzed based on predefined inclusion criteria.
RESULTS: Accumulating experimental evidence has demonstrated the therapeutic potential of TCMs for CHD, which involves numerous therapeutic approaches. TCMs and their active ingredients can alleviate CHD symptoms by acting on various pathological processes, including inflammation, oxidative stress, and endothelial damage. This review systematically summarizes and categorizes anti-CHD TCMs, their active ingredients, and corresponding prescriptions based on these therapeutic approaches.
CONCLUSION: Flavonoids, alkaloids, glycosides, and terpenoids represent the primary chemical classes contributing to CHD alleviation. Inflammatory response, oxidative stress, endothelial damage, and lipid metabolism disorder are the most frequently reported pathways through which TCMs treats CHD. Further research is needed to investigate the regulation of various and multiple relevant therapeutic targets by TCMs, as well as the correlation between its active components and therapeutic effects, in order to unveil the complex and in-depth mechanisms underlying TCM's role in alleviating CHD.
AIM OF THE REVIEW: This article provides a summary of the research developments on potential pharmacological mechanisms of TCMs formulas, TCMs extracts and chemical composition in the treatment of CHD. It aims to offer the detailed information and references for exploring new methods of treating CHD based on TCMs therapeutic strategies.
MATERIALS AND METHODS: A comprehensive literature search was conducted in databases including CNKI, Web of Science, Elsevier, and PubMed to identify studies published between 2019 and 2025 on the experimental effects of TCMs in treating CHD. The search strategy employed keywords including "coronary heart disease and traditional Chinese medicine", "coronary heart disease and inflammation", "coronary heart disease and oxidative stress", "coronary heart disease and miRNA". Retrieved articles were screened and analyzed based on predefined inclusion criteria.
RESULTS: Accumulating experimental evidence has demonstrated the therapeutic potential of TCMs for CHD, which involves numerous therapeutic approaches. TCMs and their active ingredients can alleviate CHD symptoms by acting on various pathological processes, including inflammation, oxidative stress, and endothelial damage. This review systematically summarizes and categorizes anti-CHD TCMs, their active ingredients, and corresponding prescriptions based on these therapeutic approaches.
CONCLUSION: Flavonoids, alkaloids, glycosides, and terpenoids represent the primary chemical classes contributing to CHD alleviation. Inflammatory response, oxidative stress, endothelial damage, and lipid metabolism disorder are the most frequently reported pathways through which TCMs treats CHD. Further research is needed to investigate the regulation of various and multiple relevant therapeutic targets by TCMs, as well as the correlation between its active components and therapeutic effects, in order to unveil the complex and in-depth mechanisms underlying TCM's role in alleviating CHD.